Inflammatory Flare

SAN FRANCISCO — IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease monitoring by continuously measuring biomarkers in sweat, according to the creators of the device.

Hydroxychloroquine maintenance, compared with reducing or discontinuing, is associated with a lower risk for flare among patients with systemic lupus erythematosus in remission or very low disease activity, according to data presented here.

mRNA COVID-19 vaccines were not linked to severe disease flares in patients with rheumatic diseases, although use of rituximab or mycophenolate mofetil dampened vaccine response, according to a presenter at ACR Convergence 2021.